Wearable neuromodulation device for chronic disease treatment
Cala Health manufactures FDA-regulated wearable devices for peripheral nerve stimulation, with engineering and manufacturing teams actively scaling production (NPI transfer, demand forecasting, assembly fixture design). The hiring mix—weighted toward senior engineers and manufacturing leadership—alongside pain points around supplier risk, yield, and production downtime reflects a company ramping from development into volume manufacturing while maintaining regulatory compliance.
Notable leadership hires: Manufacturing Director, Marketing Director
Cala Health designs and manufactures wearable neuromodulation therapies for chronic disease, with initial commercialization in essential tremor and pipeline programs in neurology, cardiology, and psychiatry. The company operates a hardware + firmware stack built on ARM microcontrollers (Cortex-M0, M3, M4) and Python, supported by test automation (Selenium, Cypress, Jenkins) and CAD tools (SolidWorks). Founded in 2014 and headquartered in San Mateo, California, Cala is in active production ramp phase: current priorities include FDA SAMD validation, supplier chain resilience, assembly process optimization, and demand forecasting.
Cala Health's firmware runs on ARM Cortex-M0, M3, and M4 architectures, supporting real-time neuromodulation signal processing in wearable form factors.
Current priorities include FDA compliance for SAMD software, supplier risk mitigation, production yield optimization, reducing assembly cycle time, and zero-downtime manufacturing at scale.
Other companies in the same industry, closest in size